Skip to main content
HTFL logo

HTFL · Heartflow, Inc. · Financials

Track HTFL — free
$55.99 +4.97 (+9.74%)
Market Cap
$4.44B
Shares
86.95M
Volume · Oct 20 2.89M Avg daily vol (3M) 1.82M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$176.03M +39.9%
FY2025 Revenue FY2023–FY2025
Net Income
-$116.79M -21.1%
FY2025 Net Income FY2023–FY2025
Gross Margin
76.8% +1.7pp
FY2025 Gross Margin FY2023–FY2025
Operating Margin
-36.39% +12.3pp
FY2025 Operating Margin FY2023–FY2025
Diluted EPS
-$3.17 +82.4%
FY2025 Diluted EPS FY2023–FY2025
Operating Cash Flow
-$54.02M +21.7%
FY2025 Operating Cash Flow FY2023–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) TTM FY2025 FY2024 FY2023
$246M – $250M $212.07M $176.03MG $125.81M $87.17M
— $42.24M $40.84M $31.36M $29.12M
— $169.83M $135.2M $94.45M $58.05M
— — 76.8% 75.07% 66.59%
— $83.84M $64.92M $43.52M $35.85M
— — $39.49M $30.79M $31.79M
— $158.76M $134.35M $112.15M $95.11M
— $5.32M $5.44M $5.36M $4.74M
— $250.09M $199.26M $155.67M $130.97M
— -$80.25M -$64.07M -$61.22M -$72.91M
— — -36.39% -48.66% -83.64%
— -$74.94M -$58.63M -$55.86M -$68.17M
— $3.46M $15.17M $22.77M $24.69M
— $9.13M $5.54M $4.07M $5.46M
— -$38.21M -$52.8M -$35.15M -$22.19M
— -$118.46M -$116.87M -$96.37M -$95.11M
— — -$76K $53K $547K
— -$118.37M -$116.79M -$96.43M -$95.66M
— — -66.35% -76.65% -109.73%
— — -$116.79M -$96.43M -$123.69M
— -$118.55M -$116.44M -$96.7M -$96.16M
USD/shares — $3.04 -$3.17 -$17.98 -$25.32
USD/shares — $3.04 -$3.17 -$17.98 -$25.32
shares — — 36.85M 5.36M 4.89M
shares — — 36.85M 5.36M 4.89M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Operating lease liabilities 2026-06-30 USD 27,127,000 10-Q filed 2026-08-13
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
USD 6,784,000
Noncurrent operating lease liabilities
USD 20,343,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
20.15×
Peer median 3.76×
EV/EBIT
—
Peer median 27.48×
P/E (TTM)
—
Peer median 46.26×

Peer medians compare against the 18 similar-size Health Information Services companies (of 52 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Geography (USD)

Component FY2025 FY2024 FY2023
United States $162,733,000 $115,036,000 $77,725,000
Non Us $13,301,000 $10,772,000 $9,449,000
Key facts CIK 1464521 CUSIP 42238D107 13F (30d) 20 filings 20 filers Visit website Investor relations